TLSA — Tiziana Life Sciences Cashflow Statement
0.000.00%
Last trade - 00:00
- $79.78m
- $62.03m
- 33
- 15
- 52
- 25
C2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | 20-F | 20-F |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | fx Final | fx Final | fx Final | Final | Final |
Net Income/Starting Line | -9.88 | -10 | -28.3 | -26.7 | -15.4 |
Depreciation | |||||
Non-Cash Items | 0.507 | 1.66 | 16.6 | 4.11 | -3.6 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | 4.75 | 1.31 | -0.294 | 0.642 | -0.674 |
Change in Accounts Receivable | |||||
Change in Other Assets | |||||
Change in Accounts Payable | |||||
Change in Payable / Accrued Expenses | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | -4.6 | -6.79 | -11.9 | -21.8 | -19.6 |
Capital Expenditures | 0 | -0.004 | -0.127 | -0.022 | 0 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | 0 | 0 | — | 0.152 | -4 |
Purchase of Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | 0 | -0.004 | -0.127 | 0.13 | -4 |
Financing Cash Flow Items | -1.33 | 0 | -4.02 | — | — |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 10.1 | 1.68 | 73.7 | -0.023 | -0.055 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 5.49 | -5.12 | 61.6 | -23.6 | -24.1 |